Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.

Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page has removed a detailed citation of a clinical trial related to Cabozantinib and Sunitinib, which included an erratum and additional references.SummaryDifference0.8%
- Check24 days agoChange DetectedThe web page has updated its version from v2.15.0 to v2.15.2.SummaryDifference0.1%
- Check39 days agoChange DetectedThe page has undergone significant updates, including the removal of detailed study design information for a clinical trial on metastatic renal cell carcinoma and the addition of a new version number for the study. The principal investigator's name and affiliation have also been retained.SummaryDifference27%
- Check46 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check89 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check104 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.